Alec Rodriguez EDINBURG – In a press conference, President Trump said “Tylenol during pregnancy can be associated with a very increased risk of autism,” a statement that could lead the president to a potential defamatory lawsuit from Tylenol’s parent company; Kevnue.
Louis Sorola, a Brownsville attorney, said although Tylenol’s parent company, Kevnue, could sue for defamation, President Trump is protected with sovereign immunity.
“Sovereign immunity basically protects them from any lawsuits that may stem from their official duties, much like the Supreme Court recently said that the president cannot be charged criminally for official duties,” Sorola said.
Sorola added that the only reason a lawsuit could hold up is because Trump said the brand Tylenol and not the medication acetaminophen.
However, Tylenol would need to make its case to prove the allegations are false.
UT Health Obstetrician-Gynecologist Dr. Wayne Wilson provided his medical insight on the claim of acetaminophen.
“No. There’s no, there’s no direct evidence that acetaminophen causes either autism or is potentially contributory to autism or to attention deficit hyperactivity disorder,” said Dr. Wilson.
He also said that the evidence for autism is linked to genetics rather than any prescribed drugs. 
Kevnue has not made an official initiative for a lawsuit against President Trump.
